NCT02770950

Zushima Plaster for Treating Knee Osteoarthritis

Zushima Plaster for Patients in Knee Osteoarthritis: a Random, Positive Drug Controlled, Multi-center Clinical Research

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 396 (actual)
• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to further evaluate the clinical efficacy and safety of Zushima plaster for patients in knee osteoarthrosis post-marketing.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DRUG	Zushima plaster with high dose	Patients in high dose Zushima plaster group will use Zushima plaster topically on knee(s) for 24h per day.
DRUG	Zushima plaster with low dose	Patients in low dose Zushima plaster group will use Zushima plaster topically on knee(s) for 12h per day.
DRUG	Indometacin Cataplasms	Patients in Indometacin Cataplasms group will use Indometacin Cataplasms on knee(s)for 24h per day.

Timeline

• Start date: 2016-05-01
• Primary completion: 2017-06-01
• Completion: 2017-12-01
• First posted: 2016-05-12
• Last updated: 2018-11-20

Locations

1 site across 1 country: China